Biomarkers in DNA Samples From Younger Patients With Newly Diagnosed Acute Myeloid Leukemia Receiving Gemtuzumab Ozogamicin
Completed
- Conditions
- Leukemia
- First Posted Date
- 2010-06-08
- Last Posted Date
- 2016-05-18
- Lead Sponsor
- Children's Oncology Group
- Target Recruit Count
- 300
- Registration Number
- NCT01139320
Biomarkers in Samples From Young Patients With Acute Myeloid Leukemia
Completed
- Conditions
- Leukemia
- First Posted Date
- 2010-06-07
- Last Posted Date
- 2016-05-18
- Lead Sponsor
- Children's Oncology Group
- Target Recruit Count
- 149
- Registration Number
- NCT01138306
Biomarkers in Patients With Acute Myeloid Leukemia
Completed
- Conditions
- Leukemia
- First Posted Date
- 2010-06-07
- Last Posted Date
- 2015-05-06
- Lead Sponsor
- Children's Oncology Group
- Target Recruit Count
- 18
- Registration Number
- NCT01138319
Biomarkers in Young Patients With Acute Myeloid Leukemia
Completed
- Conditions
- Leukemia
- First Posted Date
- 2010-06-07
- Last Posted Date
- 2015-05-06
- Lead Sponsor
- Children's Oncology Group
- Target Recruit Count
- 20
- Registration Number
- NCT01138332
Biomarkers in DNA Samples From Patients With High-Risk Acute Lymphoblastic Leukemia
Completed
- Conditions
- Leukemia
- First Posted Date
- 2010-05-07
- Last Posted Date
- 2016-07-11
- Lead Sponsor
- Children's Oncology Group
- Target Recruit Count
- 350
- Registration Number
- NCT01119586
Genetic Susceptibility Biomarkers in Children With Neuroblastoma (Also Known as Neuroblastoma Epidemiology in North America [NENA])
Completed
- Conditions
- Neuroblastoma
- First Posted Date
- 2010-05-07
- Last Posted Date
- 2019-01-08
- Lead Sponsor
- Children's Oncology Group
- Target Recruit Count
- 576
- Registration Number
- NCT01119560
- Locations
- πΊπΈ
Children's Hospital of Alabama, Birmingham, Alabama, United States
πΊπΈUSA Health Strada Patient Care Center, Mobile, Alabama, United States
πΊπΈPhoenix Childrens Hospital, Phoenix, Arizona, United States
Biomarkers in Tissue Samples From Patients With High-Risk Wilms Tumor
Completed
- Conditions
- Rhabdoid Tumor of the KidneyStage II Wilms TumorStage IV Wilms TumorRecurrent Wilms Tumor and Other Childhood Kidney TumorsStage I Wilms TumorStage III Wilms TumorClear Cell Sarcoma of the KidneyStage V Wilms Tumor
- First Posted Date
- 2010-05-06
- Last Posted Date
- 2016-05-19
- Lead Sponsor
- Children's Oncology Group
- Target Recruit Count
- 185
- Registration Number
- NCT01118078
- Locations
- πΊπΈ
Children's Oncology Group, Monrovia, California, United States
Maintenance Chemotherapy or Observation Following Induction Chemotherapy and Radiation Therapy in Treating Patients With Newly Diagnosed Ependymoma
Phase 3
Active, not recruiting
- Conditions
- Clear Cell EpendymomaPapillary EpendymomaAnaplastic EpendymomaCellular EpendymomaEpendymomaBrain Ependymoma
- Interventions
- Radiation: 3-Dimensional Conformal Radiation TherapyOther: Clinical ObservationOther: Laboratory Biomarker Analysis
- First Posted Date
- 2010-03-31
- Last Posted Date
- 2024-10-26
- Lead Sponsor
- Children's Oncology Group
- Target Recruit Count
- 479
- Registration Number
- NCT01096368
- Locations
- πΊπΈ
Children's Hospital of Alabama, Birmingham, Alabama, United States
πΊπΈUniversity of Alabama at Birmingham Cancer Center, Birmingham, Alabama, United States
πΊπΈBanner Children's at Desert, Mesa, Arizona, United States
Biomarkers in Bone Marrow Samples From Pediatric Patients With High-Risk Acute Myeloid Leukemia
Completed
- Conditions
- Childhood Acute Monocytic Leukemia (M5b)Recurrent Childhood Acute Myeloid LeukemiaUntreated Childhood Acute Myeloid Leukemia and Other Myeloid MalignanciesChildhood Acute Basophilic LeukemiaChildhood Acute Erythroleukemia (M6)Childhood Acute Monoblastic Leukemia (M5a)Childhood Acute Megakaryocytic Leukemia (M7)Childhood Acute Myeloblastic Leukemia With Maturation (M2)Childhood Acute Eosinophilic LeukemiaChildhood Acute Minimally Differentiated Myeloid Leukemia (M0)
- First Posted Date
- 2010-02-26
- Last Posted Date
- 2016-05-19
- Lead Sponsor
- Children's Oncology Group
- Target Recruit Count
- 250
- Registration Number
- NCT01076569
- Locations
- πΊπΈ
Children's Oncology Group, Monrovia, California, United States
Studying DNA in Tumor Tissue Samples From Patients With Localized or Metastatic Osteosarcoma
Completed
- Conditions
- Sarcoma
- First Posted Date
- 2010-02-04
- Last Posted Date
- 2015-05-06
- Lead Sponsor
- Children's Oncology Group
- Target Recruit Count
- 99
- Registration Number
- NCT01062438